lysine has been researched along with Cognition Disorders in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Q; Chen, GJ; Cheng, J; Lin, L; Liu, A; Ma, K; Matas, E; Wang, W; Wang, X; Wang, ZJ; Wei, J; Yan, Z; Zhang, F; Zheng, Y | 1 |
Barco, A; Lopez-Atalaya, JP; Parkel, S | 1 |
Ge, YS; Lin, YZ; Liu, Y; Sha, L; Shen, QF; Sun, CK; Wang, C; Xu, HZ; Zhang, JH | 1 |
Domino, EF; Kawamata, M; Nishiyama, S; Ohba, H; Takei, N; Tsukada, H; Wakuda, T; Yamamoto, S | 1 |
Gomez-Esteban, JC; Lezcano, E; Molano, A; Somme, JH; Tijero, B; Zarranz, JJ | 1 |
Cauley, JA; Harris, T; Launer, L; Lindquist, K; Rosano, C; Satterfield, S; Schwartz, AV; Simonsick, EM; Vitartas, C; Vittinghoff, E; Yaffe, K | 1 |
Dillmann, U; Erdmann, P; Papanagiotou, P; Shamdeen, MG; Sühs, KW | 1 |
Ahmed, N; Ahmed, U; Fleischer, G; Hager, K; Münch, G; Thornalley, PJ | 1 |
Doe, N; Kitamura, Y; Matsuyama, S; Mori, H; Saito, N; Tanaka, C; Taniguchi, T | 1 |
Billiar, TR; Carcillo, JA; Carlos, TM; Chen, M; Clark, RS; DeKosky, ST; Dixon, CE; Kochanek, PM; Marion, DW; Schiding, JK; Sinz, EH; Watkins, SC; Williams, D; Wisniewski, SR | 1 |
1 review(s) available for lysine and Cognition Disorders
Article | Year |
---|---|
Histone H3 lysine methylation in cognition and intellectual disability disorders.
Topics: Animals; Cognition Disorders; Epigenesis, Genetic; Histones; Humans; Intellectual Disability; Lysine; Methylation; Protein Processing, Post-Translational | 2013 |
9 other study(ies) available for lysine and Cognition Disorders
Article | Year |
---|---|
Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Chromosome Deletion; Cognition; Cognition Disorders; Cognitive Dysfunction; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Hippocampus; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Memory Disorders; Methylation; Mice; Mice, Transgenic; Prefrontal Cortex; Synapses | 2019 |
Nε-(carboxymethyl)-lysine, White Matter, and Cognitive Function in Diabetes Patients.
Topics: Aged; Anisotropy; Case-Control Studies; Cognition Disorders; Diabetes Mellitus, Type 2; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Processing, Computer-Assisted; Leukoencephalopathies; Lysine; Male; Mental Status Schedule; Neuropsychological Tests | 2016 |
Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
Topics: Animals; Brain; Brain Mapping; Carbon Isotopes; Cognition Disorders; Consciousness; Disease Models, Animal; Dose-Response Relationship, Drug; Lysine; Macaca mulatta; Magnetic Resonance Imaging; Male; Maleimides; Muscarinic Antagonists; Neuropsychological Tests; Photic Stimulation; Positron-Emission Tomography; Reaction Time; Receptors, Muscarinic; Scopolamine; Time Factors | 2011 |
Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Cognition Disorders; Disease Progression; Family Health; Female; Glutamine; Humans; Longitudinal Studies; Lysine; Male; Mutation; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Time Factors | 2011 |
Advanced glycation end product level, diabetes, and accelerated cognitive aging.
Topics: Aged; Aging; Arginine; Chi-Square Distribution; Cognition Disorders; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Longitudinal Studies; Lysine; Male; Mental Status Schedule; Neuropsychological Tests; Odds Ratio | 2011 |
Adult manifestation of L-2-hydroxyglutarate dehydrogenase deficiency by a novel mutation.
Topics: Adult; Alcohol Oxidoreductases; Brain; Cerebellar Diseases; Cognition Disorders; Disease Progression; Female; Humans; Lysine; Magnetic Resonance Imaging; Mutation; Saccades; Tremor | 2012 |
Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.
Topics: Aged; Alzheimer Disease; Biomarkers; Cerebrospinal Fluid Proteins; Cognition Disorders; Female; Glycosylation; Humans; Lysine; Male; Neuropsychological Tests; Nitrates; Nitroso Compounds; Oxidation-Reduction; Reference Values; Tyrosine | 2005 |
Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.
Topics: Alzheimer Disease; Animals; Asparagine; Avoidance Learning; Chromosomes, Human, Pair 17; Cognition Disorders; Disease Models, Animal; Hippocampus; Humans; Lysine; Maze Learning; Mice; Mice, Transgenic; Mutation, Missense; Nerve Tissue Proteins; Neurofibrillary Tangles; Phosphorylation; tau Proteins | 2005 |
Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice.
Topics: Animals; Brain Damage, Chronic; Brain Injuries; Cognition Disorders; Enzyme Induction; Enzyme Inhibitors; Guanidines; Hippocampus; Hypoxia; Lysine; Male; Maze Learning; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurons; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; Whole-Body Irradiation; Wounds, Nonpenetrating | 1999 |